Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prion protein and developments in its detection.

I MacGregor1

  • 1Products and Components Research Group, Scottish National Blood Transfusion Service, Edinburgh, UK. ian.macgregor@snbts.csa.scot.uhs.uk

Transfusion Medicine (Oxford, England)
|May 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute enteritis in subtropical climates.

British medical journal·2010
Same author

Acute Enteritis in Subtropical Climates.

British medical journal·2010
Same author

Prion protein in patients with renal failure.

Transfusion medicine (Oxford, England)·2006
Same author

The effects of leucocyte depletion on the generation and removal of microvesicles and prion related protein in blood components.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2002
Same author

Immunoassay of human plasma cellular prion protein.

Transfusion·2001
Same author

The release of prion protein from platelets during storage of apheresis platelets.

Transfusion·2001
Same journal

Novel variants of the KLF1 gene associated with the In(Lu) phenotype lead to alterations in protein structure.

Transfusion medicine (Oxford, England)·2026
Same journal

Simple image analysis for reliability control of column agglutination test in pretransfusion testing.

Transfusion medicine (Oxford, England)·2026
Same journal

First identification and molecular characterisation of a rare D- - donor in Saudi Arabia.

Transfusion medicine (Oxford, England)·2026
Same journal

Early Haemoglobin response after single-unit red blood cell transfusion predicts repeat transfusion in hospitalised adults: A prospective cohort study and clinical prediction model.

Transfusion medicine (Oxford, England)·2026
Same journal

Identification and protein modelling analysis of a homozygous FUT1*01W.09 variant in a Thai patient with the para-Bombay phenotype.

Transfusion medicine (Oxford, England)·2026
Same journal

Prioritising parameters to minimise blood transfusions for postpartum haemorrhage: A machine learning study using national population data.

Transfusion medicine (Oxford, England)·2026
See all related articles

Detecting abnormal prion protein (PrPsc) in blood is crucial for preventing variant Creutzfeldt-Jakob disease (vCJD) transmission. Current methods face challenges in sensitivity, specificity, and standardization for large-scale screening.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Transfusion Medicine

Background:

  • Variant Creutzfeldt-Jakob disease (vCJD) poses a theoretical risk of transmission through blood transfusions.
  • Abnormal prion protein (PrPsc) is the causative agent of transmissible spongiform encephalopathies, including vCJD.
  • Current safety measures include sourcing plasma internationally and implementing leucodepletion.

Purpose of the Study:

  • To review the properties of PrPsc relevant to its detection in blood.
  • To assess the feasibility and challenges of developing reliable diagnostic assays for PrPsc in blood and plasma.

Main Methods:

  • Review of existing literature on PrPsc properties and detection methods.
  • Analysis of biochemical properties like insolubility in detergents and partial proteinase K resistance for PrPsc separation.

Related Experiment Videos

  • Evaluation of antibody-based detection systems and their limitations.

    • Main Results:

    • PrPsc's unique properties allow separation from the normal PrPc isoform.
    • Established detection methods (e.g., Western blotting) are primarily optimized for brain tissue.
    • Limited data exists for blood/plasma assays, though feasibility is indicated.
    • Significant obstacles remain, including assay validation and detecting low PrPsc levels.

    Conclusions:

    • Developing sensitive and specific assays for PrPsc in blood is essential for vCJD prevention.
    • Overcoming challenges in standardization, reagent availability, and assay validation is critical.
    • Further research is needed to enable practical, large-scale screening of blood donations.